FWCGX | RLGYX | FWCGX / RLGYX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 16 years | - |
Gain YTD | 2.062 | 2.113 | 98% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 10000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 127B | 2B | 6,366% |
Annual Yield % from dividends | 1.94 | 1.29 | 150% |
Returns for 1 year | 11.26 | 12.11 | 93% |
Returns for 3 years | 11.80 | 14.19 | 83% |
Returns for 5 years | N/A | 11.54 | - |
Returns for 10 years | N/A | -0.90 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WOOQX | 18.82 | 0.10 | +0.53% |
JPMorgan SMID Cap Equity R4 | |||
EKGYX | 39.34 | 0.17 | +0.43% |
Allspring Special Global Small Cap Admin | |||
SIECX | 10.16 | 0.02 | +0.20% |
Saratoga International Equity C | |||
ETIHX | 33.85 | N/A | N/A |
Eventide Healthcare & Life Sciences I | |||
JFNIX | 67.99 | -0.36 | -0.53% |
Janus Henderson Global Life Sciences I |